Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer

Affiliations

• 1 Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.
• 2 Undergraduate Programs, University of Washington, Seattle, WA, USA.
• 3 Summer Undergraduate Research Fellowship Program, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA; Department of Integrative Biology, School of Life Sciences, College of Science, Oregon State University, Corvallis, OR, USA.
• 4 Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA; Summer Undergraduate Research Fellowship Program, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.
• 5 Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China; Department of Urology, School of Medicine and Shu-Tien Urological Research, National Yang Ming Chiao Tung University, Taipei, Republic of China.
• 6 Institute of Microbiology and Immunology, National Yang Ming Chiao Tung University, Taipei, Republic of China.
• 7 Department of Urology, University of Washington, Seattle, WA, USA.
• 8 Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
• 9 Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA; WWAMI Medical Education Program, University of Idaho, Moscow, ID, USA. Electronic address: tbland@uidaho.edu.
• 10 Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA. Electronic address: boyang.wu@wsu.edu.